222 related articles for article (PubMed ID: 15049272)
1. [New methods of therapy for ocular inflammatory autoimmune diseases].
Kubicka-Trzaska A; Undas A
Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
[TBL] [Abstract][Full Text] [Related]
2. Toward new therapies for ocular inflammation.
Rosenbaum JT; Becker MD; Smith JR
Arch Soc Esp Oftalmol; 2000 Aug; 75(8):511-4. PubMed ID: 11151211
[TBL] [Abstract][Full Text] [Related]
3. [The current outlook in the therapy of autoimmune diseases].
Sebastiani GD; Passiu G
Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
[TBL] [Abstract][Full Text] [Related]
4. Design of effective immunotherapy for human autoimmunity.
Feldmann M; Steinman L
Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
6. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
7. Scleritis: Immunopathogenesis and molecular basis for therapy.
Wakefield D; Di Girolamo N; Thurau S; Wildner G; McCluskey P
Prog Retin Eye Res; 2013 Jul; 35():44-62. PubMed ID: 23454614
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic approaches in ocular inflammatory diseases.
Kurup SK; Chan CC
Arch Immunol Ther Exp (Warsz); 2005; 53(6):484-96. PubMed ID: 16407781
[TBL] [Abstract][Full Text] [Related]
9. Immune therapies of autoimmune diseases: are we approaching a real cure?
Chatenoud L
Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.
Durrani K; Zakka FR; Ahmed M; Memon M; Siddique SS; Foster CS
Surv Ophthalmol; 2011; 56(6):474-510. PubMed ID: 22117884
[TBL] [Abstract][Full Text] [Related]
11. [Immunology in clinical practice. XIII. Immune diseases of the eye].
Ooijman FM; van der Lelij A
Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756
[TBL] [Abstract][Full Text] [Related]
12. [The current and future outlook in immunosuppressive therapy for children].
Goţia S; Ionescu C
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):35-42. PubMed ID: 9524654
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
Theodossiadis PG; Markomichelakis NN; Sfikakis PP
Retina; 2007; 27(4):399-413. PubMed ID: 17420690
[TBL] [Abstract][Full Text] [Related]
14. [Prospects of immunotropic therapy of traumatic uveitis].
Valeeva RG; Grishina VS; Iluridze SL; Isaeva RT
Vestn Oftalmol; 1998; 114(4):26-8. PubMed ID: 9771084
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation.
Commodaro AG; Bueno V; Belfort R; Rizzo LV
Autoimmun Rev; 2011 Feb; 10(4):205-9. PubMed ID: 20959149
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic prospects in autoimmunity].
Revillard JP
Rev Prat; 1994 Jan; 44(1):93-7. PubMed ID: 8178066
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmune dermatoses: new therapeutic strategies].
Trüeb RM
Praxis (Bern 1994); 2000 Sep; 89(37):1460-7. PubMed ID: 11037617
[TBL] [Abstract][Full Text] [Related]
18. [Indication and effect of immunosuppression in patients with scleritis].
Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
[TBL] [Abstract][Full Text] [Related]
19. Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety.
Durrani K; Papaliodis GN; Foster CS
Ophthalmology; 2004 May; 111(5):960-5. PubMed ID: 15121375
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
Tognon S; Graziani G; Marcolongo R
Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
